Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis

Published:2022-09-03 Issue:11 Volume:78 Page:1727-1737
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Dai Jianfeng,Gong Jing,Guo Rui

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-022-03376-1.pdf

Reference26 articles.

1. Bauer MP, Notermans DW, van Benthem BHB et al (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet Lond Engl 377:63–73. https://doi.org/10.1016/S0140-6736(10)61266-4

2. Tytgat F (1980) Rate of isolation of “C. difficile” from stools of hospitalized patients: susceptibility of 75 strains (author’s transl). Ann Microbiol (Paris) 131B:11–20

3. Teasley DG, Gerding DN, Olson MM et al (1983) Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet Lond Engl 2:1043–1046. https://doi.org/10.1016/s0140-6736(83)91036-x

4. Wenisch C, Parschalk B, Hasenhündl M et al (1996) Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis Off Publ Infect Dis Soc Am 22:813–818. https://doi.org/10.1093/clinids/22.5.813

5. Venugopal AA, Johnson S (2012) Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. Clin Infect Dis Off Publ Infect Dis Soc Am 54:568–574. https://doi.org/10.1093/cid/cir830

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options;Clinical Microbiology Reviews;2024-06-13

2. The Clinical Effectiveness of Fidaxomicin Compared to Vancomycin in the Treatment of Clostridioides difficile Infection, A Single-Center Real-World Experience;The Journal of Infectious Diseases;2024-05-23

3. Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study;Heliyon;2024-05

4. The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-01

5. Microbiome-preserving antibiotics for the treatment of Clostridioides difficile infection: a systematic review and meta-analysis;Techniques in Coloproctology;2023-12-19